Kangmei Pharma | 600518 - Cost Of Sales


Kangmei Pharma reported CNY841.45M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Akebia Therapeutics USD 10.34M 441K Dec/2025
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.3M 166K Dec/2025
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
Genomma Lab Internacional MXN 1.53B 34.69M Mar/2026
Hypermarcas BRL 858.94M 6.26M Dec/2025
Ionis Pharmaceuticals USD 3M 5M Mar/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
Jiangsu Hengrui CNY 1.09B 76.27M Mar/2026
Kangmei Pharma CNY 841.45M 271.27M Mar/2026
Moderna USD 955M 503M Mar/2026
Organon & Co USD 766M 21M Dec/2025
Revvity USD 323.46M 26.93M Mar/2026
Sh Fosun Pharma CNY 5.07B 507.9M Mar/2026
Viatris USD 2.36B 195.9M Mar/2026
Wuxi Apptec CNY 6.17B 95.51M Mar/2026
Xeris Pharmaceuticals USD 13.66M 49K Dec/2025
Zz Pientze Pharmaceu CNY 1.58B 245.15M Mar/2026